Consultant in paediatric inherited metabolic diseases, Royal Manchester Children's Hospital, United Kingdom
Simon Jones is a consultant in paediatric inherited metabolic diseases at the Willink Unit at St. Mary’s Hospital in Manchester, UK. His major research interest is therapy for lysosomal storage diseases (LSDs). He received his medical training at the Edinburgh University Medical School, Edinburgh, UK, with a BSc in Neurosciences. He moved to London and trained in Paediatrics at Guy’s and St. Thomas’ Hospital, London, UK. He has been working at the Willink Biochemical Genetics Unit in Manchester, UK since September 2005. Since 2008, he has been a consultant in paediatric inherited metabolic diseases at the Willink Unit and is now the clinical lead for the LSD service. The Willink Unit is now part of the Manchester Centre for Genomic Medicine at St. Mary’s Hospital, Manchester, UK. He is the medical director of the NIHR Manchester children’s clinical research facility. Dr Jones has been actively involved in many phase I-IV international multicentre trials of novel therapies for LSDs. He is currently the principal investigator in a number of LSD trials and a senior lecturer at the University of Manchester. He is an author of over 60 peer-reviewed papers and 3 book chapters. When not working, he watches Liverpool Football club and spends time with his family.
ENT Association and Board Member of the European Society of Pediatric Otorhinolaryngology. He has also represented the Turkish Medical Association in the European Union of Medical Specialists (UEMS) for many years and is a Board Member of the CME/CPD Coordination Committee of Medical Specialist Societies in the Turkish Medical Association.